Boston, Massachusetts
Elevian develops regenerative medicines that target root-cause aging mechanisms. Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. By targeting root-cause aging mechanisms, Elevian’s therapeutics have the potential to treat or prevent multiple degenerative diseases and extend healthy lifespan.

Dr. Mark Allen

Stay Tuned

Subscribe to our newsletter and get updates on our portfolio companies.